Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of Zurich
ClinicalTrials.gov Identifier:
NCT01598805
First received: May 11, 2012
Last updated: November 15, 2012
Last verified: November 2012
  Purpose

Now, after a cluster randomized controlled trial, eAlerts providing evidence-based guidelines on venous thromboembolism prophylaxis will be rolled out and evaluated hospital-widely.


Condition Intervention
Venous Thromboembolism
Behavioral: electronic alerts

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Subject)
Primary Purpose: Health Services Research
Official Title: Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts

Resource links provided by NLM:


Further study details as provided by University of Zurich:

Primary Outcome Measures:
  • Rate of prophylaxis against venous thromboembolism [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    patients with prophylaxis/total patients


Secondary Outcome Measures:
  • ordering time after admission or transfer of a patient [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    time when physicians order a venous thromboembolism prophylaxis

  • acceptance of the eAlerts [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    survey of compliant and incompliant physicians


Enrollment: 10000
Study Start Date: June 2012
Study Completion Date: September 2012
Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: roll out of eAlerts
Roll out of eAlerts providing evidence-based guidelines on prophylaxis against venous thromboembolism. An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer.
Behavioral: electronic alerts
An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer.
Other Name: eAlert

Detailed Description:

An eAlert is displayed in the electronic patient chart if no prophylaxis has been ordered within 6 h after admission or transfer. The eAlerts provide evidence-based guidelines on venous thromboembolism prophylaxis. Now, after a cluster randomized controlled trial, the eAlerts will be rolled out and evaluated hospital-widely.

  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria:

  • all in-patients hospitalized in a ward with computerized physician order entry (CPOE),
  • staying at least 24 h in a ward

Exclusion criteria:

  • outpatients,
  • ward without CPOE,
  • patients transferred from an intervention to a control ward and vice versa
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01598805

Locations
Switzerland
University Hospital Zurich, Center for Clinical Research
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Investigators
Principal Investigator: Juerg Blaser, Prof. PhD University Hospital Zurich, Center for Clinical Research, Research Center for Medical Informatics
  More Information

No publications provided

Responsible Party: University of Zurich
ClinicalTrials.gov Identifier: NCT01598805     History of Changes
Other Study ID Numbers: FZMI-KEK-ZH-Nr. 2010-0458
Study First Received: May 11, 2012
Last Updated: November 15, 2012
Health Authority: Switzerland: Ethikkommission

Keywords provided by University of Zurich:
venous thromboembolism/prevention & control

Additional relevant MeSH terms:
Thromboembolism
Venous Thromboembolism
Venous Thrombosis
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Thrombosis

ClinicalTrials.gov processed this record on July 24, 2014